Lv1
64 积分 2024-08-19 加入
Application of process analytical technology in tablet process development using NIR spectroscopy: Blend uniformity, content uniformity and coating thickness measurements
5天前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
10天前
已完结
Blend Uniformity and Content Uniformity in Oral Solid Dosage Manufacturing: an IQ Consortium Industry Position Paper
11天前
已完结
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
1个月前
已完结
Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight
1个月前
已完结
Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms
2个月前
已完结
Surface Enrichment and Depletion of the Active Ingredient in Spray Dried Amorphous Solid Dispersions
4个月前
已完结
Improved Protocol and Data Analysis for Accelerated Shelf-Life Estimation of Solid Dosage Forms
4个月前
已完结
Modeling moisture change of packaged dry tablet dosage forms under consumer use condition
4个月前
已完结
Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility
6个月前
已完结
皖公网安备34019202002308
